ebomi
Colour theme
Sign in
Insider · CIK 0001350855

Efficacy Capital, Ltd.

CIK 0001350855 Name as filed on the most recent filing

Filed as Efficacy Capital, Ltd. (24)

60 transaction lines · from 24 filings · filed 2007-11-02 to 2011-03-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-03-16 S, Open-market sale Aeolus Pharmaceuticals, Inc.AOLS 2,317,622, disposed Open Form 4 filing 0001140361-11-017510
2011-03-15 S, Open-market sale Aeolus Pharmaceuticals, Inc.AOLS 146,858, disposed Open Form 4 filing 0001140361-11-017510
2011-02-16 S, Open-market sale Aeolus Pharmaceuticals, Inc.AOLS 55,872, disposed Open Form 4 filing 0001140361-11-010589
2011-02-15 S, Open-market sale Aeolus Pharmaceuticals, Inc.AOLS 6,650, disposed Open Form 4 filing 0001140361-11-010589
2009-12-21 S, Open-market sale Repros Therapeutics Inc.RPRX 50,202, disposed Open Form 4 filing 0001140361-09-029903
2009-12-18 S, Open-market sale Repros Therapeutics Inc.RPRX 20,280, disposed Open Form 4 filing 0001140361-09-029903
2009-12-17 S, Open-market sale Repros Therapeutics Inc.RPRX 35,220, disposed Open Form 4 filing 0001140361-09-029903
2009-12-15 S, Open-market sale Repros Therapeutics Inc.RPRX 121,739, disposed Open Form 4 filing 0001140361-09-029245
2009-12-14 S, Open-market sale Repros Therapeutics Inc.RPRX 54,452, disposed Open Form 4 filing 0001140361-09-029245
2009-12-11 S, Open-market sale Repros Therapeutics Inc.RPRX 88,044, disposed Open Form 4 filing 0001140361-09-029245
2009-12-02 S, Open-market sale Repros Therapeutics Inc.RPRX 182,273, disposed Open Form 4 filing 0001140361-09-027917
2009-12-01 S, Open-market sale Repros Therapeutics Inc.RPRX 92,800, disposed Open Form 4 filing 0001140361-09-027917
2009-11-30 S, Open-market sale Repros Therapeutics Inc.RPRX 105,480, disposed Open Form 4 filing 0001140361-09-027917
2009-11-23 S, Open-market sale Repros Therapeutics Inc.RPRX 159,195, disposed Open Form 4 filing 0001140361-09-027215
2009-11-20 S, Open-market sale Repros Therapeutics Inc.RPRX 151,984, disposed Open Form 4 filing 0001140361-09-027215
2009-11-19 S, Open-market sale Repros Therapeutics Inc.RPRX 160,222, disposed Open Form 4 filing 0001140361-09-027215
2008-10-31 P, Open-market purchase Repros Therapeutics Inc.RPRX 87,688, acquired Open Form 4 filing 0001104659-08-067952
2008-10-29 P, Open-market purchase Repros Therapeutics Inc.RPRX 170,068, acquired Open Form 4 filing 0001104659-08-067039
2008-10-28 P, Open-market purchase Repros Therapeutics Inc.RPRX 67,958, acquired Open Form 4 filing 0001104659-08-067039
2008-10-27 P, Open-market purchase Repros Therapeutics Inc.RPRX 101,551, acquired Open Form 4 filing 0001104659-08-066016
2008-10-24 P, Open-market purchase Repros Therapeutics Inc.RPRX 206,700, acquired Open Form 4 filing 0001104659-08-066016
2008-10-23 P, Open-market purchase Repros Therapeutics Inc.RPRX 109,393, acquired Open Form 4 filing 0001104659-08-066016
2008-10-17 P, Open-market purchase Repros Therapeutics Inc.RPRX 192,600, acquired Open Form 4 filing 0001104659-08-065013
2008-10-13 P, Open-market purchase Repros Therapeutics Inc.RPRX 102,300, acquired Open Form 4 filing 0001104659-08-064095
2008-10-10 P, Open-market purchase Repros Therapeutics Inc.RPRX 95,319, acquired Open Form 4 filing 0001104659-08-064095
2008-10-02 P, Open-market purchase Repros Therapeutics Inc.RPRX 12,000,001, acquired Open Form 4 filing 0001104659-08-062364
2008-03-27 S, Open-market sale Repros Therapeutics Inc.RPRX 532,890, disposed Open Form 4 filing 0001104659-08-044049
2008-03-26 S, Open-market sale Repros Therapeutics Inc.RPRX 98,200, disposed Open Form 4 filing 0001104659-08-044049
2008-03-25 S, Open-market sale Repros Therapeutics Inc.RPRX 574,800, disposed Open Form 4 filing 0001104659-08-044049
2008-03-24 S, Open-market sale Repros Therapeutics Inc.RPRX 480,500, disposed Open Form 4 filing 0001104659-08-044049
2008-03-20 S, Open-market sale Repros Therapeutics Inc.RPRX 303,960, disposed Open Form 4 filing 0001104659-08-044049
2008-03-18 S, Open-market sale Repros Therapeutics Inc.RPRX 94,340, disposed Open Form 4 filing 0001104659-08-044049
2008-03-17 S, Open-market sale Repros Therapeutics Inc.RPRX 472,749, disposed Open Form 4 filing 0001104659-08-044049
2008-03-14 S, Open-market sale Repros Therapeutics Inc.RPRX 225,917, disposed Open Form 4 filing 0001104659-08-044049
2008-03-12 P, Open-market purchase Repros Therapeutics Inc.RPRX 425,000, acquired Open Form 4 filing 0001104659-08-017478
2008-03-10 P, Open-market purchase Repros Therapeutics Inc.RPRX 338,400, acquired Open Form 4 filing 0001104659-08-016855
2008-03-07 P, Open-market purchase Repros Therapeutics Inc.RPRX 297,735, acquired Open Form 4 filing 0001104659-08-016855
2008-02-29 P, Open-market purchase Repros Therapeutics Inc.RPRX 248,100, acquired Open Form 4 filing 0001104659-08-014848
2008-02-28 P, Open-market purchase Repros Therapeutics Inc.RPRX 167,000, acquired Open Form 4 filing 0001104659-08-014848
2008-01-07 P, Open-market purchase Repros Therapeutics Inc.RPRX 177,060, acquired Open Form 4 filing 0001104659-08-001299
2008-01-04 P, Open-market purchase Repros Therapeutics Inc.RPRX 134,400, acquired Open Form 4 filing 0001104659-08-001299
2007-12-31 P, Open-market purchase Repros Therapeutics Inc.RPRX 510,163, acquired Open Form 4 filing 0001104659-08-000255
2007-12-28 P, Open-market purchase Repros Therapeutics Inc.RPRX 652,400, acquired Open Form 4 filing 0001104659-08-000255
2007-12-21 P, Open-market purchase Repros Therapeutics Inc.RPRX 375,200, acquired Open Form 4 filing 0001104659-07-090718
2007-12-20 P, Open-market purchase Repros Therapeutics Inc.RPRX 569,400, acquired Open Form 4 filing 0001104659-07-090718
2007-12-19 P, Open-market purchase Repros Therapeutics Inc.RPRX 428,040, acquired Open Form 4 filing 0001104659-07-090170
2007-12-18 P, Open-market purchase Repros Therapeutics Inc.RPRX 412,159, acquired Open Form 4 filing 0001104659-07-090170
2007-12-14 P, Open-market purchase Repros Therapeutics Inc.RPRX 1,173,600, acquired Open Form 4 filing 0001104659-07-089559
2007-12-13 P, Open-market purchase Repros Therapeutics Inc.RPRX 348,870, acquired Open Form 4 filing 0001104659-07-089559
2007-12-06 P, Open-market purchase Repros Therapeutics Inc.RPRX 477,600, acquired Open Form 4 filing 0001104659-07-087805

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Efficacy Capital, Ltd., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001350855

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.